NCT06286839View on ClinicalTrials.gov

Study of Cannabidiol (CBD) in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

October 28, 2022

Study Completion Date

December 14, 2022

Conditions
Immune System and Related DisordersImmune System Diseases
Interventions
DIETARY_SUPPLEMENT

Cannabidiol (CBD)

Cannabidiol (CBD), a non-psychoactive component of Cannabis sativa L.

Trial Locations (1)

60611

Altantia Clinical Trials, Chicago

Sponsors
All Listed Sponsors
collaborator

Atlantia Food Clinical Trials

INDUSTRY

lead

NextEvo Inc.

INDUSTRY

NCT06286839 - Study of Cannabidiol (CBD) in Healthy Volunteers | Biotech Hunter | Biotech Hunter